ICU Medical
ICUI
243 hedge funds and large institutions have $3.78B invested in ICU Medical in 2022 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 83 increasing their positions, 90 reducing their positions, and 37 closing their positions.
912% more call options, than puts
Call options by funds: $24.8M | Put options by funds: $2.46M
14.84% more ownership
Funds ownership: 90.34% → 105.18% (+15%)
7% more capital invested
Capital invested by funds: $3.55B → $3.78B (+$232M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 90
6% less funds holding
Funds holding: 258 → 243 (-15)
35% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 37
Top Buyers
Top Sellers
ICUI Hedge Fund Activity: Q3 2022 in Review
243 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in ICU Medical (ICUI) for Q3 2022, worth a combined $3.78B — up 6.5% from $3.55B a quarter earlier.
Sellers outnumbered buyers: 37 funds closed out of ICUI and 24 opened new positions — a net loss of 13 holders — while 90 trimmed existing stakes and 83 added.
The largest buyer was Janus Henderson Group, adding an estimated $410M. The largest seller was T. Rowe Price Associates, cutting an estimated $406M.
- 243 institutional investors held ICU Medical (ICUI) as of Q3 2022, down from 258 in Q2 2022.
- Funds reported $3.78B of ICU Medical stock for Q3 2022, up 6.5% quarter-over-quarter.
- 24 funds opened new ICU Medical positions in Q3 2022 and 37 closed out, a net change of -13 holders.
- The largest ICU Medical buyer in Q3 2022 was Janus Henderson Group, an estimated $410M added.
- The largest ICU Medical seller in Q3 2022 was T. Rowe Price Associates, an estimated $406M sold.
Based on aggregated 13F filings for Q3 2022.